Kumdee, C., J. Yadee, W. Pantumongkol, P. Hadnorntun, N. Kittiratchakul, P. Leelahavarong, N. Suchonwanich, and C. Ekakkararungroj. “Consequences and Enablers of the Selection of High-Cost Medicines to the National List of Essential Medicines Category E(2)”. Journal of Health Systems Research, vol. 15, no. 4, Dec. 2021, pp. 456-7, https://he04.tci-thaijo.org/index.php/j_hsr/article/view/3300.